Name
GS2-05 - Randomized comparisons of adjuvant exemestane + ovarian function suppression (OFS) vs tamoxifen + OFS vs tamoxifen in premenopausal women with HR+ early breast cancer: update of the TEXT and SOFT trials
Date & Time
Tuesday, December 7, 2021
Speakers
Virtual Session Link